IBDEI07P ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10094,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,10094,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,10095,0)
 ;;=224.0^^64^621^11
 ;;^UTILITY(U,$J,358.3,10095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10095,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,10095,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,10095,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,10096,0)
 ;;=364.72^^64^621^6
 ;;^UTILITY(U,$J,358.3,10096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10096,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,10096,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,10096,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,10097,0)
 ;;=364.71^^64^621^102
 ;;^UTILITY(U,$J,358.3,10097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10097,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,10097,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,10097,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,10098,0)
 ;;=364.00^^64^621^57
 ;;^UTILITY(U,$J,358.3,10098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10098,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,10098,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,10098,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,10099,0)
 ;;=379.40^^64^621^106
 ;;^UTILITY(U,$J,358.3,10099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10099,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,10099,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,10099,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,10100,0)
 ;;=190.0^^64^621^84
 ;;^UTILITY(U,$J,358.3,10100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10100,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,10100,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,10100,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,10101,0)
 ;;=190.3^^64^621^83
 ;;^UTILITY(U,$J,358.3,10101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10101,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,10101,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,10101,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,10102,0)
 ;;=364.41^^64^621^50
 ;;^UTILITY(U,$J,358.3,10102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10102,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,10102,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,10102,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,10103,0)
 ;;=364.05^^64^621^51
 ;;^UTILITY(U,$J,358.3,10103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10103,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,10103,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,10103,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,10104,0)
 ;;=365.02^^64^621^4
 ;;^UTILITY(U,$J,358.3,10104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10104,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,10104,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,10104,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,10105,0)
 ;;=372.63^^64^621^117
 ;;^UTILITY(U,$J,358.3,10105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10105,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,10105,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,10105,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,10106,0)
 ;;=372.75^^64^621^27
 ;;^UTILITY(U,$J,358.3,10106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10106,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,10106,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,10106,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,10107,0)
 ;;=364.81^^64^621^43
 ;;^UTILITY(U,$J,358.3,10107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10107,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,10107,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,10107,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,10108,0)
 ;;=006.9^^64^621^2
 ;;^UTILITY(U,$J,358.3,10108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10108,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,10108,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,10108,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,10109,0)
 ;;=190.8^^64^621^60
 ;;^UTILITY(U,$J,358.3,10109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10109,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,10109,1,4,0)
 ;;=4^190.8
 ;;^UTILITY(U,$J,358.3,10109,2)
 ;;=^267278
 ;;^UTILITY(U,$J,358.3,10110,0)
 ;;=224.1^^64^621^93
 ;;^UTILITY(U,$J,358.3,10110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10110,1,3,0)
 ;;=3^Orbit Neoplasm,Benign
 ;;^UTILITY(U,$J,358.3,10110,1,4,0)
 ;;=4^224.1
 ;;^UTILITY(U,$J,358.3,10110,2)
 ;;=^267671
 ;;^UTILITY(U,$J,358.3,10111,0)
 ;;=360.33^^64^621^52
 ;;^UTILITY(U,$J,358.3,10111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10111,1,3,0)
 ;;=3^Hypotony,Assoc w/ Ocular D/O
 ;;^UTILITY(U,$J,358.3,10111,1,4,0)
 ;;=4^360.33
 ;;^UTILITY(U,$J,358.3,10111,2)
 ;;=^268560
 ;;^UTILITY(U,$J,358.3,10112,0)
 ;;=224.8^^64^621^86
 ;;^UTILITY(U,$J,358.3,10112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10112,1,3,0)
 ;;=3^Neopl Eye Bgn,Oth Iris Nevus
 ;;^UTILITY(U,$J,358.3,10112,1,4,0)
 ;;=4^224.8
 ;;^UTILITY(U,$J,358.3,10112,2)
 ;;=^267678
 ;;^UTILITY(U,$J,358.3,10113,0)
 ;;=364.01^^64^621^103
 ;;^UTILITY(U,$J,358.3,10113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10113,1,3,0)
 ;;=3^Prim Iridocyclitis
 ;;^UTILITY(U,$J,358.3,10113,1,4,0)
 ;;=4^364.01
 ;;^UTILITY(U,$J,358.3,10113,2)
 ;;=^268704
 ;;^UTILITY(U,$J,358.3,10114,0)
 ;;=364.04^^64^621^53
 ;;^UTILITY(U,$J,358.3,10114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10114,1,3,0)
 ;;=3^Iridociclyties 2ary,Non Infectious
 ;;^UTILITY(U,$J,358.3,10114,1,4,0)
 ;;=4^364.04
 ;;^UTILITY(U,$J,358.3,10114,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,10115,0)
 ;;=364.21^^64^621^46
 ;;^UTILITY(U,$J,358.3,10115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10115,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,10115,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,10115,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,10116,0)
 ;;=364.23^^64^621^81
 ;;^UTILITY(U,$J,358.3,10116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10116,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,10116,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,10116,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,10117,0)
 ;;=364.51^^64^621^8
 ;;^UTILITY(U,$J,358.3,10117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10117,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,10117,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,10117,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,10118,0)
 ;;=364.53^^64^621^100
 ;;^UTILITY(U,$J,358.3,10118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10118,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,10118,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,10118,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,10119,0)
 ;;=364.57^^64^621^33
 ;;^UTILITY(U,$J,358.3,10119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10119,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,10119,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,10119,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,10120,0)
 ;;=364.60^^64^621^26
 ;;^UTILITY(U,$J,358.3,10120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10120,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,10120,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,10120,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,10121,0)
 ;;=364.73^^64^621^97
 ;;^UTILITY(U,$J,358.3,10121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10121,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,10121,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,10121,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,10122,0)
 ;;=364.75^^64^621^107
 ;;^UTILITY(U,$J,358.3,10122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10122,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,10122,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,10122,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,10123,0)
 ;;=364.76^^64^621^58
 ;;^UTILITY(U,$J,358.3,10123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10123,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,10123,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,10123,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,10124,0)
 ;;=364.77^^64^621^3
 ;;^UTILITY(U,$J,358.3,10124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10124,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,10124,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,10124,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,10125,0)
 ;;=364.89^^64^621^62
 ;;^UTILITY(U,$J,358.3,10125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10125,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
 ;;^UTILITY(U,$J,358.3,10125,1,4,0)
 ;;=4^364.89
 ;;^UTILITY(U,$J,358.3,10125,2)
 ;;=^268745
 ;;^UTILITY(U,$J,358.3,10126,0)
 ;;=364.9^^64^621^61
 ;;^UTILITY(U,$J,358.3,10126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10126,1,3,0)
 ;;=3^Iris/Ciliary Body D/O,Unspec
 ;;^UTILITY(U,$J,358.3,10126,1,4,0)
 ;;=4^364.9
 ;;^UTILITY(U,$J,358.3,10126,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,10127,0)
 ;;=370.00^^64^621^25
 ;;^UTILITY(U,$J,358.3,10127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10127,1,3,0)
 ;;=3^Corneal Ulcer NOS
 ;;^UTILITY(U,$J,358.3,10127,1,4,0)
 ;;=4^370.00
 ;;^UTILITY(U,$J,358.3,10127,2)
 ;;=^28441
 ;;^UTILITY(U,$J,358.3,10128,0)
 ;;=370.20^^64^621^66
 ;;^UTILITY(U,$J,358.3,10128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10128,1,3,0)
 ;;=3^Keratitis,Superfic Unspec
 ;;^UTILITY(U,$J,358.3,10128,1,4,0)
 ;;=4^370.20
 ;;^UTILITY(U,$J,358.3,10128,2)
 ;;=^268918
 ;;^UTILITY(U,$J,358.3,10129,0)
 ;;=370.31^^64^621^99
 ;;^UTILITY(U,$J,358.3,10129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10129,1,3,0)
 ;;=3^Phlyctenule Keratoconj
 ;;^UTILITY(U,$J,358.3,10129,1,4,0)
 ;;=4^370.31
 ;;^UTILITY(U,$J,358.3,10129,2)
 ;;=^268928^017.30
 ;;^UTILITY(U,$J,358.3,10130,0)
 ;;=370.8^^64^621^65
 ;;^UTILITY(U,$J,358.3,10130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10130,1,3,0)
 ;;=3^Keratitis,Oth Forms
 ;;^UTILITY(U,$J,358.3,10130,1,4,0)
 ;;=4^370.8
 ;;^UTILITY(U,$J,358.3,10130,2)
 ;;=^87595
 ;;^UTILITY(U,$J,358.3,10131,0)
 ;;=371.24^^64^621^23
